Recombinant Human TRPM7/LTRPC7 Protein, N-His from ProteoGenix; catalogue ARO-P11512; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human TRPM7/LTRPC7 Protein, also known as Transient Receptor Potential Melastatin 7/Long Transient Receptor Potential Channel 7, is a protein that plays a crucial role in cellular and physiological processes. This protein is encoded by the TRPM7 gene and is a member of the transient receptor potential (TRP) family of ion channels. In this article, we will discuss the structure, activity, and application of Recombinant Human TRPM7/LTRPC7 Protein.
Recombinant Human TRPM7/LTRPC7 Protein is a large protein consisting of 1866 amino acids with a molecular weight of approximately 206 kDa. It is composed of six transmembrane domains, a cytoplasmic N-terminus, and a cytoplasmic C-terminus. The N-terminus contains a kinase domain, which is responsible for the protein’s autophosphorylation activity. The C-terminus contains a coiled-coil domain, which is involved in protein-protein interactions.
Recombinant Human TRPM7/LTRPC7 Protein is a non-selective cation channel that allows the passage of various ions, including magnesium, calcium, and zinc, across the cell membrane. It is also a bifunctional protein with both ion channel and kinase activities. The ion channel activity is regulated by changes in the concentration of intracellular magnesium and plays a crucial role in maintaining cellular magnesium homeostasis. The kinase activity of TRPM7 is involved in the regulation of cellular processes such as cell proliferation, cell survival, and cell migration.
Recombinant Human TRPM7/LTRPC7 Protein has various applications in both research and therapeutic fields. Some of the major applications are listed below:
Recombinant Human TRPM7/LTRPC7 Protein is widely used in research to study its structure, function, and role in various physiological processes. It is also used to investigate the role of TRPM7 in diseases such as cancer, neurodegenerative disorders, and cardiovascular diseases. Recombinant TRPM7 protein is also used to screen and identify potential inhibitors or activators of the channel and kinase activities.
The ion channel and kinase activities of Recombinant Human TRPM7/LTRPC7 Protein make it a potential target for drug development. Inhibitors of TRPM7 have been shown to have anti-cancer properties, making it a promising target for cancer treatment. Additionally, TRPM7 inhibitors have also been investigated for their potential in treating neurodegenerative disorders and cardiovascular diseases.
Recombinant Human TRPM7/LTRPC7 Protein can also be used as a diagnostic tool to detect the presence of autoantibodies against TRPM7 in patients with certain autoimmune diseases. These autoantibodies have been shown to be associated with the development of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis.
Recombinant Human TRPM7/LTRPC7 Protein has also been studied as a potential antigen for vaccine development. Studies have shown that TRPM7 is expressed in various types of cancer cells and is involved in cancer cell survival and proliferation. Therefore, targeting TRPM7 with a vaccine may induce an immune response against cancer cells, making it a potential therapeutic strategy in cancer treatment.
The kinase activity of TRPM7 has been shown to play a crucial role in cell survival and migration. This makes Recombinant Human TRPM7/LTRPC7 Protein a potential candidate for cell-based therapies.
ProteoGenix catalogue number ARO-P11512. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 39.70 kDa; Fragment: Gly93-Gly431; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
